Cancer Research
How the Microbiome Drives Cancer and Could Unlock Better Treatments
A sweeping 2025 review maps how gut, tumor, and systemic microbiomes promote or suppress cancer across every major tumor type.
Article de recherche
23 avr. 2026 0
Sujet
Cancer
Latest breakthroughs in cancer research, treatment, and prevention
602 articles
Cancer Research
Bacteria Living Inside Tumors Drive Cancer Spread and Open New Treatment Doors
A comprehensive review reveals how intracellular bacteria colonize cancer cells, fuel metastasis, and can be weaponized against tumors.
Article de recherche
23 avr. 2026 0
Cancer Research
Magnetic Bacteria Eaten as Pills Destroy Colon Tumors and Rewire Gut Microbiome
Engineered magnetotactic bacteria delivered orally penetrate colorectal tumors, trigger immune attack, and reshape gut microbial metabolism in mice.
Article de recherche
23 avr. 2026 0
Cancer Research
Chemotherapy Triggers Gut Bacteria to Block Cancer Spread via Immune Rewiring
A gut metabolite produced after chemo reprograms bone marrow immune cells, creating a lasting shield against colorectal cancer liver metastasis.
Article de recherche
23 avr. 2026 0
Cancer Research
Scientists Find Master Switch That Fuels Melanoma Growth and Blocks Immune Attack
A protein called HOXD13 drives skin cancer growth and shields tumors from immune cells — disabling it could unlock powerful new treatments.
Communiqué de presse
22 avr. 2026 0
Cancer Research
Tumors Hijack the Brain's Nervous System to Suppress Your Immune Defenses
A Nature study reveals lung tumors activate vagal nerves to drive sympathetic signaling that shuts down anti-tumor immunity.
Article de recherche
22 avr. 2026 0
Cancer Research
Nerve Activity Drives Lung Cancer Growth — Cutting the Vagus Nerve Slows Tumors
Neuronal signals fuel small cell lung cancer via the vagus nerve and direct neuron-to-tumor synapses, opening new therapeutic targets.
Article de recherche
22 avr. 2026 0
Cancer Research
86 Cancer Drugs Mapped Against 758 Kinases Opens New Repurposing Possibilities
A landmark screen of approved kinase inhibitors reveals 94% of cancer mutations are already targetable — and uncovers surprising new drug uses.
Article de recherche
22 avr. 2026 0
Cancer Research
FDA Grants Accelerated Approval to Zongertinib for HER2-Mutant Lung Cancer
Zongertinib (Hernexeos) wins FDA accelerated approval for HER2-driven non-small cell lung cancer, offering a targeted oral option.
Approbation de médicament
21 avr. 2026 0
Cancer Research
Massive 50,000-Tumor Study Reveals How Cancer Mutations Vary by Tumor Type
A landmark genomic analysis of 50,000 tumors maps cancer-driving mutations across tumor types, revealing critical patterns that could reshape precision oncology.
Article de recherche
21 avr. 2026 0
Cancer Research
Processed Foods and Breast Cancer Risk — Alcohol Is the Real Culprit
A 13-year Italian cohort study finds ultra-processed foods don't raise breast cancer risk, but alcoholic beverages do.
Article de recherche
21 avr. 2026 0
Cancer Research
FDA Approves Keytruda Combo for Platinum-Resistant Ovarian Cancer
Pembrolizumab plus chemotherapy gains FDA approval for PD-L1-positive ovarian cancer patients who failed prior treatment.
Approbation de médicament
20 avr. 2026 0